2nd Annual Treatment Updates in Demyelinating Disorders of CNS and Myasthenia Gravis (11/20/26)

Friday, November 20, 2026, 7:00 AM - 3:30 PM, HFH - Detroit - Martha Firestone & William Clay Ford Hall A, Detroit, MI


AMA PRA Category 1 Credits™ (6.00 hours), AMA PRA Non-Physician Attendance (6.00 hours)

The past few years have been very exciting in the multiple sclerosis (MS), demyelinating disorders of central nervous system ( NMOSD, MOGAD) and myasthenia gravis (MG) field. There have been quite a few new treatments approved lately for management of MS, NMOSD, MG. We have gathered some of the best experts in neurology, infection disease, hepatology, surgery and obstetrics to answer the most commonly encountered questions regarding the complex treatment management and monitoring of patients with MS, NMOSD, MG.

1. Demonstrate knowledge of diagnosis criteria of multiple sclerosis and demyelinating disorders of central nervous system.
2. Demonstrate knowledge of Myasthenia gravis classification and clinical assessment
3. Demonstrate knowledge of new immunomodulatory and immunosuppressive treatments of MS, NMOSD, MG and monitoring requirements of each treatment
4. Address and discuss with patients' treatment of MS, NMOSD, MG in pregnancy, postpartum/breastfeeding
5. Become familiar with plasma exchange treatment in acute presentations of MS, NMOSD, MG
6. Demonstrate familiarity with surgical treatment indication for MG
7. Demonstrate familiarity with required immunization, treatment of infections with immunosuppressive therapy for MS, NMOSD, MG

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: Henry Ford Health designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credit™(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

ACCESSIBILITY STATEMENT: 

The Henry Ford Health Office of Continuing Medical Education is committed to ensuring that its programs, services, goods, and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act and the ADA Amendments Act of 2008. If you have needs that require special accommodations, please contact Tina Miller at [email protected].

The Henry Ford Health Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, November 20, 2026